Clinical Trial Update: Alloantibodies in Pediatric Heart Transplantation

View source ↗

Summary

A NIH-sponsored trial evaluating alloantibodies in pediatric heart transplantation was terminated, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplantation

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Pediatric Heart Transplantation, Pediatric Heart Transplant Recipients | Status: TERMINATED | Results posted: 2017-04-20